首页
OALib 期刊
快速投稿通道
我的图书馆
常见问题
关于我们
关注我们+
Biomedical & Life Sciences
Business & Economics
Chemistry & Materials Science
Computer Science & Communications
Engineering
Medicine & Healthcare
Physics & Mathematics
Social Sciences & Humanities
Biomedical & Life Sciences
Business & Economics
Chemistry & Materials Science
Computer Science & Communications
Engineering
Medicine & Healthcare
Physics & Mathematics
Social Sciences & Humanities
LinkedIn (OALib Group)
LinkedIn (OALib Company Page)
Facebook
Twitter
全部
标题
作者
关键词
摘要
OALib Journal期刊
ISSN: 2333-9721
费用：99美元
投递稿件
为什么选择我们？
>>
- 开源期刊
- 同行审议
- 快速出刊
- 终身存储
- 免费检索
- 免费推广
- 更多...
- 搜索引擎
-
ISSN Print: 1476-5365
ISSN Online:
主页:
https://www.nature.com/bmt
分享:
Go
Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from pathogenesis to forthcoming treatment modalities
Pre-hematopoietic cell transplant Ruxolitinib in patients with primary and secondary myelofibrosis
Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)
Autologous stem cell transplantation in patients with AL amyloidosis with impaired renal function
Unit selection for umbilical cord blood transplantation for adults with acute myeloid leukemia in complete remission: a Japanese experience
Psychophysical effects of an exercise therapy during pediatric stem cell transplantation: a randomized controlled trial
High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantation
Incidence and predictors of severe cardiotoxicity in patients with severe aplastic anaemia after haploidentical haematopoietic stem cell transplantation
Pharmacokinetics analysis results are similar for oral compared to intravenous busulfan in patients undergoing hematopoietic stem cell transplantation, except for the earlier onset of mucositis. A controlled clinical study
Post-transplant cyclophosphamide use in matched HLA donors: a review of literature and future application
Direct adjusted survival and cumulative incidence curves for observational studies
Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019
CRISPR/Cas9-modified hematopoietic stem cells—present and future perspectives for stem cell transplantation
Fevers post infusion of T-cell replete hla mismatched haploidentical hematopoietic stem cells with post-transplant cyclophosphamide: risk factors and impact on transplant outcomes
Retrospective single center analysis of outcome, risk factors and therapy in steroid refractory graft-versus-host disease after allogeneic hematopoietic cell transplantation
A phase I/II study of escalating doses of thalidomide in conjunction with bortezomib and high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma
Transplant center practices for psychosocial assessment and management of pediatric hematopoietic stem cell donors
Haploidentical CD3 or α/β T-cell depleted HSCT in advanced stage sickle cell disease
Red blood cell transfusion burden by day 30 predicts mortality in adults after single-unit cord blood transplantation
Fertility preservation from the point of view of hematopoietic cell transplant specialists—a worldwide-web-based survey analysis
Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALL
Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry
Advances in hematopoietic stem cell transplantation in the Asia-Pacific region: the second report from APBMT 2005–2015
Cord blood research, banking, and transplantation: achievements, challenges, and perspectives
Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome
Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting
Effects of HLA mismatch on cytomegalovirus reactivation in cord blood transplantation
Treatment of Epstein–Barr virus associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation with intrathecal donor lymphocyte infusion
Incidence, significance, and persistence of human coronavirus infection in hematopoietic stem cell transplant recipients
A retrospective analysis of haplo-identical HLA-mismatch hematopoietic transplantation without posttransplantation cyclophosphamide for GVHD prophylaxis in patients with adult T-cell leukemia–lymphoma
Melphalan dose in myeloma patients ≥65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry study
Allogeneic stem cell transplantation for patients with relapsed or refractory T-cell lymphoma: efficacy of lymphoma-directed conditioning against advanced disease
Chemotherapy plus DLI for relapse after haploidentical HSCT: the biological characteristics of relapse influences clinical outcomes of acute leukemia patients
Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT
The role of stem cell transplantation in the management of relapsed follicular lymphoma in the era of targeted therapies
Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation combined with unrelated cord blood for patients with hematologic malignancies: a prospective, phase II study
Clinical impact of clonal hematopoiesis in acute myeloid leukemia patients receiving allogeneic transplantation
Post-transplantation cyclophosphamide-based haploidentical versus Atg-based unrelated donor allogeneic stem cell transplantation for patients younger than 60 years with hematological malignancies: a single-center experience of 209 patients
Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugs
Reduced intensity vs. myeloablative conditioning with fludarabine and PK-guided busulfan in allogeneic stem cell transplantation for patients with AML/MDS
One single bone marrow harvesting from donors under 3 years of age: assessing safety and efficacy of the procedure
Real-life feasibility of salvage allogeneic transplantation in peripheral T-cell lymphomas
A survey on incidence and management of adenovirus infection after allogeneic HSCT
Safety and efficacy of rituximab-based first line treatment of chronic GVHD
Cytarabine？+？G-CSF is more effective than cyclophosphamide？+？G-CSF as a stem cell mobilization regimen in multiple myeloma
Strategies to improve outcomes of autologous hematopoietic cell transplant in lymphoma
Safety and efficacy of propylene glycol-free melphalan as conditioning in patients with AL amyloidosis undergoing stem cell transplantation
Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation
Impact of low-dose irradiation and in vivo T-cell depletion on hematopoietic stem cell transplantation for non-malignant diseases using fludarabine-based reduced-intensity conditioning
Antithymocyte globulin for graft-versus-host disease prophylaxis: an updated systematic review and meta-analysis
Go
